Search

Your search keyword '"Carmisciano L."' showing total 138 results

Search Constraints

Start Over You searched for: Author "Carmisciano L." Remove constraint Author: "Carmisciano L."
138 results on '"Carmisciano L."'

Search Results

1. Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study

3. Signs and symptoms of COVID-19 in patients with multiple sclerosis

4. P033 The assessment of serum cytokines at baseline could predict mucosal healing in patients with Crohn's disease treated with ustekinumab. A prospective study

5. P678 Ustekinumab therapy improves the nutritional status in patients with Crohn's Disease. A prospective study

6. Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy

7. Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis

8. The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis

9. Signs and symptoms of COVID-19 in patients with multiple sclerosis

10. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

11. Nonlesional Sources of Contrast Enhancement on Postgadolinium “Black-Blood” 3D T1-SPACE Images in Patients with Multiple Sclerosis

14. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

16. The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?

17. DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France: a pooled analysis from Italy and France

18. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

20. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

24. Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis

26. Assessing upper limb function in multiple sclerosis using an engineered glove

29. Usefulness of the ‘two‐step method’ of digital follow‐up for early‐stage melanoma detection in high‐risk French patients: a retrospective 4‐year study

32. Effect of SARS-CoV-2 mRNA vaccination in multiple sclerosis patients treated with disease modifying therapies

33. 3 Young Investigator Awardee - Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella (GIM) and Mammella Intergruppo trials (MIG).

34. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

35. Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis

36. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

37. A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting

38. Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib

39. Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis

40. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

41. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

42. Digital work engagement among Italian neurologists

43. First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study

44. Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [ 18 F]PSMA-1007 PET/CT.

45. Association of inflammatory markers with incident heart failure or cancer in the HUNT3 and Health ABC population studies.

46. Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.

47. Creating an automated tool for a consistent and repeatable evaluation of disability progression in clinical studies for multiple sclerosis.

48. MRI assessment of seminal vesicle involvement by prostate cancer using T2 signal intensity and volume.

49. Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot Study.

50. Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials.

Catalog

Books, media, physical & digital resources